TCI GENE Inc. (TPEX:6879)
Taiwan · Delayed Price · Currency is TWD 34.00
0.00 (0.00%)
Aug 3, 2026, 12:22 PM CST
TCI GENE Market Cap
TCI GENE has a market cap or net worth of 899.59 million as of August 4, 2026. Its market cap has decreased by -22.73% in one year.
Market Cap
899.59M
Enterprise Value
98.83M
Revenue
273.61M
Ranking
n/a
PE Ratio
22.37
Stock Price
34.00
ChartMarket Cap Chart
Since January 25, 2022, TCI GENE's market cap has decreased from 2.14B to 899.59M, a decrease of -57.87%. That is a compound annual growth rate of -17.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 899.59M | -4.23% |
| Dec 31, 2025 | 939.28M | -34.50% |
| Dec 26, 2024 | 1.43B | -35.55% |
| Dec 29, 2023 | 2.23B | -28.42% |
| Dec 30, 2022 | 3.11B | 45.61% |
| Jan 25, 2022 | 2.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LabTurbo Biotech | 1.10B |
| U-Neuron Biomedical | 1.09B |
| Bio Preventive Medicine | 1.07B |
| Level Biotechnology | 1.03B |
| GeneReach Biotechnology | 994.21M |
| Lukas Biomedical | 979.86M |
| Holy Stone Healthcare | 912.34M |
| Meribank Biotech | 872.42M |